HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

Adler J, Galanko JA, Ammoury R, Benkov KJ, Bousvaros A, Boyle B, Cabrera JM, Chun KY, Dorsey J, Ebach DR, Firestine AM, Gulati AS, Herfarth HH, Jester TW, Kaplan JL, Leibowitz I, Linville TM, Margolis PA, Minar P, Molle-Rios Z, Moses J, Olano K, Pashankar DS, Pitch L, Saeed SA, Samson CM, Sandberg K, Steiner SJ, Strople JA, Sullivan JS, Wali PD, Kappelman MD

Open source

DOI
10.14309/ajg.0000000000003135
Published
2025 May 1
Container
The American journal of gastroenterology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14309/ajg.0000000000003135,
  title = {HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.},
  author = {Adler J and Galanko JA and Ammoury R and Benkov KJ and Bousvaros A and Boyle B and Cabrera JM and Chun KY and Dorsey J and Ebach DR and Firestine AM and Gulati AS and Herfarth HH and Jester TW and Kaplan JL and Leibowitz I and Linville TM and Margolis PA and Minar P and Molle-Rios Z and Moses J and Olano K and Pashankar DS and Pitch L and Saeed SA and Samson CM and Sandberg K and Steiner SJ and Strople JA and Sullivan JS and Wali PD and Kappelman MD},
  year = {2025},
  journal = {The American journal of gastroenterology},
  doi = {10.14309/ajg.0000000000003135},
  url = {https://doi.org/10.14309/ajg.0000000000003135}
}

RIS

TY  - JOUR
TI  - HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.
AU  - Adler J
AU  - Galanko JA
AU  - Ammoury R
AU  - Benkov KJ
AU  - Bousvaros A
AU  - Boyle B
AU  - Cabrera JM
AU  - Chun KY
AU  - Dorsey J
AU  - Ebach DR
AU  - Firestine AM
AU  - Gulati AS
AU  - Herfarth HH
AU  - Jester TW
AU  - Kaplan JL
AU  - Leibowitz I
AU  - Linville TM
AU  - Margolis PA
AU  - Minar P
AU  - Molle-Rios Z
AU  - Moses J
AU  - Olano K
AU  - Pashankar DS
AU  - Pitch L
AU  - Saeed SA
AU  - Samson CM
AU  - Sandberg K
AU  - Steiner SJ
AU  - Strople JA
AU  - Sullivan JS
AU  - Wali PD
AU  - Kappelman MD
PY  - 2025
JO  - The American journal of gastroenterology
DO  - 10.14309/ajg.0000000000003135
UR  - https://doi.org/10.14309/ajg.0000000000003135
ER  - 

APA

J, A., JA, G., R, A., KJ, B., A, B., B, B., JM, C., KY, C., J, D., DR, E., AM, F., AS, G., HH, H., TW, J., JL, K., I, L., TM, L., PA, M., P, M., Z, M., J, M., K, O., DS, P., L, P., SA, S., CM, S., K, S., SJ, S., JA, S., JS, S., PD, W., & MD, K. (2025). HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.. The American journal of gastroenterology. https://doi.org/10.14309/ajg.0000000000003135

Source records